| Comparison of Diagnostic Performance of Preoperative PET-CT for Patients with and without Neoadjuvant Therapy in Non-Small Cell Lung Cancer: Does Induction Therapy Affect the Preoperative PET-CT Results? | SONER GÜRSOY,Ahmet ÜÇVET,Ahmet E. ERBAYCU,Esra YAMANSAVCI,Hakan KOPARAL,Engin ÖZBİLEK,Seyda O. KAYA | 143–152 |
| The Prognostic and Predictive Value of Expression of P-AKT in Patients with FIGO IIB Locally Advanced Cervical Cancer under Chemotherapy | Mihriban E KOCAK,Nagehan O BARISIK,Cengiz GEMİCİ,Makbule EREN,Murat NAKİ,Naciye ÖZŞEKER,Atınç AKSU,ALPASLAN MAYADAĞLI | 153–159 |
| Is Histopathologic Subtype of Lung Cancer Changing over Time? | Şevket ÖZKAYA,Serhat FINDIK,Atilla G. ATICI,Bedri KANDEMİR,Levent ERKAN | 160–165 |
| Orbital Exenterations: Our experience at Ankara Oncology Research And Training Hospital | Rahmi DUMAN,Mehmet BALCI,Reşat DUMAN,Sibel ÖZDOĞAN | 166–170 |
| The Fourier Transform Infrared (FTIR) Spectroscopic and Mass Spectrometric Metabolomics Studies of Ankaferd Hemostat | Duygu O DEMIRALP,Naşit İĞCİ,Yusuf ÖZTÜRK,Yavuz BEYAZIT,İbrahim C. HAZNEDAROĞLU | 171–177 |
| Combination of Cyclophosphamide and Carboplatin in Recurrent Malignant Gliomas | Umut DEMİRCİ,Süleyman BÜYÜKBERBER,Nuriye ÖZDEMİR,Uğur COŞKUN,Halit KARACA,Müge AKMANSU,Emel YAMAN,Meltem BAYKARA,Deniz YAMAÇ,Aytuğ ÜNER,Mustafa BENEKLİ | 178–183 |
| The Comparison of Standard and Salvage Chemotherapy Regimens Regarding to CD34(+) Peripheric Stem Cell Harvesting Success | Özlem Ş. BALÇIK,Cafer AKSOY,Derya AKDENİZ,Cigdem AKKAYA,Birol GÜVENÇ,Süleyman DİNÇER | 184–192 |
| Common Complications in Beta-Thalassemia Patients | Ayhan YAMAN,Pamir IŞIK,HÜSNİYE NEŞE YARALI,Selmin KARADEMİR,Semra ÇETİNKAYA,Ali BAY,Serdar ÖZKASAP,Abdurrahman KARA,Bahattin TUNÇ | 193–199 |
| Isolated Pulmonary Metastasis Presenting with an CEA Elevation Five Years After Radical Prostatectomy | Yüksel ÜRÜN,Güngör UTKAN,Sibel PERÇİNEL,Ayten K. CANGIR,Mutlu DOĞAN,Fikri İÇLİ | 200–201 |
| Paravertebral Extramedullary Tumors with Chronic Myelogenous Leukemia | Tomohiro YAMAKAWA,Mitsutoshi KUROSAWA,Hiroaki SUZUKI | 202–203 |
| A Rare Case of Castleman's Disease of Plasma Cell Type Complicated with Membranoproliferative Glomerulonephritis 1 , | Mehtap E. UYAR,Emre TUTAL,Zeynep BAL,Eylem AKAR,Sema KARAKUŞ,SİREN SEZER | 204–206 |
| A Rare Case of Castleman's Disease of Plasma Cell Type Complicated with Membranoproliferative Glomerulonephritis 1 , | Siren SEZER, Emre TUTAL, Eylem AKAR, Zeynep BAL, Mehtap E. UYAR, Sema KARAKUS | 204–206 |
| Tyrosine Kinase Inhibitors in Thyroid Cancer: May Axl/Gas6 Pathway be a Hidden Target? | S. Mehlika ISILDAK,Neslihan B. TUTUNCU,Özden ALTUNDAĞ | 207–212 |